Which is better Aromasin or Femara?

Studies show people who take aromatase inhibitors after breast cancer surgery remain free of breast cancer for five or more years after treatment. Aromatase inhibitor therapy has side effects that may affect your quality of life. If you’re taking an aromatase inhibitor, ask your healthcare provider about ways to reduce side effects so you can continue treatment that helps you live free of breast cancer.

Drugs.com Printable Discount Card

Mild side effects of many drugs may go away within a few days or a couple of weeks. But if they become bothersome, talk with your doctor or pharmacist. Aromasin is a brand-name drug that contains the active ingredient exemestane.

• Mild side effects of many drugs may go away within a few days or a couple of weeks.
• Find a list of questions on hormone therapy you may want to ask your health care provider.
• Females with early breast cancer often have low levels of vitamin D.
• Work with your doctor and compare the costs of the medications that are recommended for you.
• Share your concerns about affording medications with your prescriber.

Exemestane (Aromasin) is in a class of medications called aromatase inhibitors. Exemestane (Aromasin) works by decreasing the amount of estrogen produced by the body. Exemestane (Aromasin) is also used to treatestrogen sensitive breast cancer in women who have experienced menopause whose breast cancer has worsened while they were taking tamoxifen. Aromatase inhibitors are approved to reduce the risk of recurrence in postmenopausal women with estrogen receptor-positive breast cancer. They can also be used to treat advanced breast cancer, including stage 4 breast cancer, in which the malignancy has spread (metastasized) to other parts of the body.

Can aromatase inhibitors lower the risk of breast cancer?

To get the most benefit out of hormone therapy, you need the full recommended https://suporte.valenca.ba.gov.br/masteron-100-mg-prime-dosage/ course of treatment. Learn more about ovarian suppression and aromatase inhibitors. Before you begin taking an aromatase inhibitor, talk with your health care provider about possible side effects and how to manage them. Talk with your health care provider about how long you should take an aromatase inhibitor. For example, a doctor might prescribe this therapy for someone who hasn’t yet undergone menopause and is taking medication to reduce the functions of the ovaries, including estrogen production.

Once you’ve completed treatment, you may be considered in remission if five years have passed and you don’t have cancer symptoms and tests don’t find signs of cancer. Aromatase inhibitors work by reducing the amount of estrogen in your body. It also regulates important processes in your skeletal, cardiovascular and central nervous systems that affect your overall health. Before menopause, the ovaries produce most of the body’s estrogen.

They only lower estrogen levels in women whose ovaries aren’t making estrogen such as women who have already gone through menopause (post-menopausal women). Because of this, they are used mainly in women who have gone through menopause already. Despite these benefits, aromatase inhibitors can cause significant side effects, including accelerated bone loss leading to osteoporosis. Some people may start treatment with an aromatase inhibitor or take tamoxifen for a few years and then start aromatase inhibitor therapy. We talked with Layman to learn more about these hormone therapy drugs, which are available only to women who’ve completed menopause. The female hormone estrogen is “fuel” for about 80% of breast cancers in women who’ve gone through menopause.

With off-label use, a drug that’s approved for certain conditions is used for another purpose. Common side effects of Letrozole include hot flashes, night sweats, fatigue, dizziness, headache, somnolence, abdominal discomfort, nausea, arthralgias, weight gain and rash 25. Uncommon, but potentially severe side effects of Letrozole include decrease in bone mineral density, increases in serum cholesterol levels and embryo-fetal toxicity 25. After five years of use, an estimated one of out of every 10 women on aromatase inhibitors will experience a fracture due to drug-induced osteoporosis. Extended, 5 to 10 year treatment of women with early breast cancer who have previously received tamoxifen therapy.